Infinity Pharmaceuticals | INFI - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Eisai JPY 75.89B 9.6B 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Grifols EUR 987.75M 47.87M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Infinity Pharmaceuticals USD 1.5M 433K 2023-06
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
J&J USD 10.46B 1.53B 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Plus Therapeutics 5.92M 5.7M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
TG Therapeutics USD 148.84M 41.34M 2026-03